Literature DB >> 21277243

Differential central pain processing following repetitive intramuscular proton/prostaglandin E₂ injections in female fibromyalgia patients and healthy controls.

Martin Diers1, Marcus T Schley, Mariela Rance, Pinar Yilmaz, Lydia Lauer, Roman Rukwied, Martin Schmelz, Herta Flor.   

Abstract

BACKGROUND: While the etiology of fibromyalgia syndrome (FMS) remains unclear, it is assumed that both peripheral and central components are involved. AIMS/
METHODS: To investigate central activation patterns following chemically-induced muscle pain we repetitively injected protons (low pH) and prostaglandin E(2) (PGE(2)) in isotonic solution into the left extensor carpi radialis brevis muscle of female FMS patients and female healthy control subjects (HC). The injection of protons/PGE(2) has the advantage that it is not prone to tachyphylaxis compared to capsaicin and hypotonic saline solution. During the repetitive injections continuous pain ratings were recorded and functional magnetic resonance imaging measurements were conducted.
RESULTS: Injection of protons/PGE(2) led to activation of the anterior and medial cingulate cortices, contralateral primary sensory cortex, bilateral insula and thalamus, left basal ganglia, left orbitofrontal cortex and the cerebellum in FMS patients. In HC, activations were found only in the anterior, medial, and posterior cingulate cortices, and the primary somatosensory cortex. The contrast between the groups revealed significantly stronger activation for FMS patients in the left anterior insula. Peak pain ratings were comparable between HC and FMS patients, but pain duration (sustained pain) was prolonged in FM.
CONCLUSION: Repetitive proton/PGE(2)-induced excitation of muscle tissue led to a more prolonged perception of pain and more wide-spread activation in pain-related brain areas in FMS, especially in the left (ipsilateral) insula, whereas acute protons/PGE(2)-induced pain processing was similar in the two groups. These data provide further evidence for enhanced central pain processing in FMS patients.
Copyright © 2011 European Federation of International Association for the Study of Pain Chapters. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21277243     DOI: 10.1016/j.ejpain.2010.12.002

Source DB:  PubMed          Journal:  Eur J Pain        ISSN: 1090-3801            Impact factor:   3.931


  7 in total

1.  Anatomical and physiological factors contributing to chronic muscle pain.

Authors:  Nicholas S Gregory; Kathleen A Sluka
Journal:  Curr Top Behav Neurosci       Date:  2014

Review 2.  Sex-based differences in brain alterations across chronic pain conditions.

Authors:  Arpana Gupta; Emeran A Mayer; Connor Fling; Jennifer S Labus; Bruce D Naliboff; Jui-Yang Hong; Lisa A Kilpatrick
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

3.  Age-Dependent Sexual Dimorphism in Susceptibility to Develop Chronic Pain in the Rat.

Authors:  Luiz F Ferrari; Dioneia Araldi; Paul Green; Jon D Levine
Journal:  Neuroscience       Date:  2017-07-01       Impact factor: 3.590

4.  Pharmacotherapy for fibromyalgia.

Authors:  Howard S Smith; Donna Bracken; Joshua M Smith
Journal:  Front Pharmacol       Date:  2011-03-31       Impact factor: 5.810

5.  Neurobiology underlying fibromyalgia symptoms.

Authors:  Marta Ceko; M Catherine Bushnell; Richard H Gracely
Journal:  Pain Res Treat       Date:  2011-10-27

Review 6.  Gray Matter Atrophy within the Default Mode Network of Fibromyalgia: A Meta-Analysis of Voxel-Based Morphometry Studies.

Authors:  Chemin Lin; Shwu-Hua Lee; Hsu-Huei Weng
Journal:  Biomed Res Int       Date:  2016-12-26       Impact factor: 3.411

Review 7.  Systematic Review of the Use of Intravenous Ketamine for Fibromyalgia.

Authors:  Mila Pastrak; Alaa Abd-Elsayed; Frederick Ma; Bruce Vrooman; Ognjen Visnjevac
Journal:  Ochsner J       Date:  2021
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.